ARK Invest Sells AMD Shares Following Stock Surge
On November 13, ARK Invest made a decisive move by selling 87,051 shares of Advanced Micro Devices (AMD), a position valued at $22.5 million, marking a shift in their investment portfolio. This sale came on the heels of a 10% surge in AMD’s stock price, fueled by their November 11 Analyst Day presentation that highlighted AI advancements and data center strategies. The stock closed at $247.96, following a 4% drop that day, as ARK strategically capitalized on short-term gains.
Rebalancing the Portfolio: From Semiconductors to Crypto
In an effort to diversify their investments, ARK Invest reduced its stake in other technology companies as well. Notable reductions include the sale of 572,735 Pinterest shares worth $15.6 million, and the complete sell-off of Regeneron shares (12,083 shares totaling $8.2 million). Additionally, 21,974 Salesforce shares were sold, valued at approximately $5.4 million.
Investing Big in Cryptocurrency
In a bold move reflecting growing confidence in the digital payments and blockchain sectors, ARK invested heavily in cryptocurrency-focused companies. The fund acquired 188,941 shares of Circle Internet Group—responsible for powering the USDC stablecoin—across three ETFs. Altogether, the purchases totaled $16.3 million. This marked the second consecutive day of Circle-related purchases, highlighting ARK’s belief in the potential of digital currencies in the payments market.
ARK further deepened its involvement in cryptocurrency infrastructure by purchasing 242,347 shares of Bitmine Immersion Technologies, a crypto mining solutions provider. This $9.8 million investment aligns with ARK’s strategy to support blockchain innovations such as mining operations, complementing their Circle holdings. Notably, ARK allocated over $26 million into cryptocurrency-based assets, balancing out the sell-off of AMD shares.
Biotech Investments Continue
Another key area of ARK Invest’s focus is the biotechnology sector. The fund acquired 140,193 shares of gene-editing company Beam Therapeutics, amounting to a $3.1 million investment during a week of consistent accumulation. Additionally, 261,439 Recursion Pharmaceuticals shares were added for $1.2 million, signaling ARK’s commitment to innovative health solutions.
Why This Matters to Investors
ARK Invest’s activity demonstrates a clear pivot toward emerging industries, particularly digital assets and cutting-edge healthcare technologies. Investors looking to stay ahead of market trends should consider exploring similar opportunities, whether in blockchain infrastructure or biotech advancements.
Top Recommendation
If you’re interested in the crypto sector, consider exploring USDC-backed assets for stability in volatile markets. Additionally, for individual biotech exposure, Beam Therapeutics could be a great starting point, given its gene-editing technology and strong backing from ARK Invest.
